Santiago
Muñoz Fernández
Publicaciones en las que colabora con Santiago Muñoz Fernández (10)
2023
-
Correction to: Validation of UVEDAI: An Index for Evaluating the Level of Inflammatory Activity in Uveitis (Ophthalmology and Therapy, (2023), 12, 2, (1045-1055), 10.1007/s40123-023-00654-8)
Ophthalmology and Therapy
-
SER recommendations for the treatment of uveitis
Reumatologia Clinica, Vol. 19, Núm. 9, pp. 465-477
-
Validation of UVEDAI: An Index for Evaluating the Level of Inflammatory Activity in Uveitis
Ophthalmology and Therapy, Vol. 12, Núm. 2, pp. 1045-1055
2021
-
Inflammatory Relapses after Immunosuppressive Drug Discontinuation in Uveitis Patients: A Survival Analysis
Ocular Immunology and Inflammation, Vol. 29, Núm. 2, pp. 376-387
-
Measuring Choroid Thickness as a Marker of Systemic Inflammation in Patients with Ankylosing Spondylitis
Journal of Clinical Rheumatology, Vol. 27, Núm. 8, pp. E307-E311
2020
-
Choroidal Thickness Is a Biomarker Associated With Response to Treatment in Ankylosing Spondylitis
JCR: Journal of Clinical Rheumatology
2019
-
Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases
Arthritis and Rheumatology, Vol. 71, Núm. 12, pp. 2081-2089
-
Visual acuity loss and development of ocular complications in white dot syndromes: a longitudinal analysis of 3 centers
Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 257, Núm. 11, pp. 2505-2516
2018
-
Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease
Ophthalmology, Vol. 125, Núm. 9, pp. 1444-1451
2017
-
Development of an activity disease score in patients with uveitis (UVEDAI)
Rheumatology International, Vol. 37, Núm. 4, pp. 647-656